Medicine and Dentistry
Facioscapulohumeral Muscular Dystrophy
100%
Patient
79%
Magnetic Resonance Imaging
64%
Muscle
55%
Cells
52%
Myofibrosis
52%
Retrospective Cohort Study
52%
Biological Marker
52%
Muscle Disease
31%
Muscle Atrophy
27%
Fibrosis
27%
Distal Myopathy
26%
Phenotype
17%
Survival
17%
Disease Activity
17%
Disease Exacerbation
15%
Combination Therapy
11%
Diseases
11%
Amyotrophic Lateral Sclerosis
8%
Differential Diagnosis
8%
Vacuolization
8%
Muscle Weakness
8%
Motor Neuron
8%
Pathology
8%
Prognosis
8%
Drive
5%
Association
5%
Differentiation
5%
Mesenchymal Stem Cell
5%
Pathogenesis
5%
Tissue Regeneration
5%
Stem Cell Niche
5%
Cell Interaction
5%
Neuromuscular Disease
5%
Age
5%
Paracetamol
5%
Marker
5%
Cell Population
5%
Resident
5%
In Vitro
5%
Skeletal Muscle
5%
Adipocyte
5%
Adipose Tissue
5%
Clinical Trial
5%
Fat Content
5%
Autosomal Dominant Inheritance
5%
Biopsy
5%
Edema
5%
Muscle Injury
5%
Non Invasive Procedure
5%
Biochemistry, Genetics and Molecular Biology
Magnetic Resonance Imaging
58%
SOD1
52%
Spectrum
17%
Phenotype
17%
Survival
17%
Lower Motor Neuron
8%
Skeletal Muscle
5%
Tissue Regeneration
5%
Stromal Cell
5%
Drive
5%
Adipocyte
5%
Age
5%
Cell-Cell Interaction
5%
Association
5%
PDGFRA
5%
Stem Cell
5%
Neuroscience
Muscular Dystrophy
52%
SOD1
52%
Magnetic Resonance Imaging
31%
Muscle Disorder
26%
Phenotype
17%
Lower Motor Neuron
8%
Amyotrophic Lateral Sclerosis
8%
Differential Diagnosis
8%
Staining Technique
5%
Adipose Tissue
5%
